Bg pattern

CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Clopidogrel Farmalid 75 mg film-coated tablets EFG

Clopidogrel, besylate

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Clopidogrel Farmalid and what is it used for
  2. What you need to know before taking Clopidogrel Farmalid
  3. How to take Clopidogrel Farmalid
  4. Possible side effects
  5. Storage of Clopidogrel Farmalid
  6. Package contents and additional information

1. What is Clopidogrel Farmalid and what is it used for

Clopidogrel Farmalid belongs to a group of medications called antiplatelet agents. Platelets are very small cells found in the blood, smaller than red or white blood cells, and they aggregate when blood clots. Antiplatelet agents, by preventing this aggregation, reduce the likelihood of blood clots (a process called thrombosis) forming.

Clopidogrel Farmalid is administered to prevent the formation of blood clots (thrombi) in hardened blood vessels (arteries), a process known as atherothrombosis, which can cause atherothrombotic events (such as cerebral infarction, myocardial infarction, or death). You have been prescribed Clopidogrel Farmalid to help prevent the formation of blood clots and reduce the risk of these serious events, as:

  • You suffer from a process that causes hardening of the arteries (also called atherosclerosis), and
  • You have previously suffered a myocardial infarction, a cerebral infarction, or suffer from a disease called peripheral arteriopathy.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Clopidogrel Farmalid

Do not take Clopidogrel Farmalid:

  • if you are allergic to clopidogrel or any of the other components of this medication (listed in section 6).
  • if you have an active bleeding disorder, such as a stomach ulcer or bleeding in the brain.
  • if you have a severe liver disease;

If you think any of these may apply to you, or if you have any doubts, consult your doctor before taking Clopidogrel.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Clopidogrel Farmalid.

Before starting treatment with Clopidogrel Farmalid, inform your doctor if you are in any of the following situations:

  • If you are at risk of bleeding (bleeding) because:
    • You have a disease that involves a risk of internal bleeding (such as a stomach ulcer).
    • You have a blood disorder that predisposes you to internal bleeding (bleeding in tissues, organs, or joints of the body).
    • You have recently had a serious injury.
    • You have recently undergone surgery (including dental surgery).
    • You are scheduled to undergo surgery (including dental surgery) within the next seven days.
  • If you have had a blood clot in a brain artery (ischemic cerebral infarction) in the last 7 days.
  • If you are taking other medications (see "Use of other medications").
  • If you have liver or kidney disease.

During treatment with Clopidogrel Farmalid:

  • Inform your doctor if you are scheduled to undergo surgery (including dental surgery).
  • Inform your doctor immediately if you develop a disorder that includes fever and bruising (bruises) under the skin that can appear as localized red spots, with or without unexplained extreme fatigue, confusion, yellow color of the skin or eyes (jaundice) (see section 4 "POSSIBLE SIDE EFFECTS").
  • If you cut or injure yourself, the bleeding may take longer than usual to stop. This is related to the way the medication works, as it prevents the blood's ability to form clots. For minor cuts or injuries, such as cuts while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Take special care with Clopidogrel").
  • Your doctor may ask you to have blood tests.
  • Inform your doctor or pharmacist if you notice any side effects not mentioned in section 4 of "POSSIBLE SIDE EFFECTS" or if you notice that any side effect worsens.

Children and adolescents

Clopidogrel Farmalid should not be administered to children or adolescents.

Taking Clopidogrel Farmalid with other medications

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Some medications may affect the use of Clopidogrel or vice versa.

Concomitant administration of Clopidogrel with oral anticoagulants (medications used to decrease blood clotting) is not recommended.

You must explicitly inform your doctor if you are taking ticlopidine, another antiplatelet agent, non-steroidal anti-inflammatory drugs, medications commonly used to treat pain and/or inflammation of muscles or joints, or if you are taking heparin, or any other medication used to decrease blood clotting, if you are taking a proton pump inhibitor (e.g., omeprazole) for stomach discomfort or if you are taking antiretrovirals (medications for treating HIV infection).

A dose of acetylsalicylic acid administered occasionally (not exceeding 1,000 mg in 24 hours) should not cause any problems, but prolonged use in other circumstances should be discussed with your doctor.

Taking Clopidogrel Farmalid with food and beverages

Clopidogrel Farmalid can be taken with or without food.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

It is preferable not to use this medication during pregnancy and breastfeeding.

Driving and using machines

Clopidogrel is unlikely to affect your ability to drive or operate machinery.

This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

3. How to take Clopidogrel Farmalid

Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist again.

The recommended dose is one 75 mg tablet of Clopidogrel Farmalid per day, administered orally, with or without food, and at the same time each day.

You should take Clopidogrel Farmalid for as long as your doctor continues to prescribe it.

If you take more Clopidogrel Farmalid than you should

Contact your doctor or go to the nearest hospital emergency department, as there is a higher risk of bleeding. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20 (indicating the medication and the amount ingested).

If you forget to take Clopidogrel Farmalid

If you forget to take a dose of Clopidogrel Farmalid, but remember before 12 hours have passed since the time you should have taken the medication, take the tablet immediately and the next one at the usual time.

If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for the missed doses.

In the 7, 14, 28, and 84 tablet formats, you can check the last day you took a Clopidogrel tablet by looking at the calendar printed on the blister pack.

If you interrupt treatment with Clopidogrel Farmalid

Do not interrupt your treatment. Contact your doctor or pharmacist before stopping this medication.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, Clopidogrel Farmalid can have side effects, although not everyone will experience them.

Contact your doctor immediately if you experience:

  • Fever, signs of infection, or severe fatigue. These symptoms may be due to a rare decrease in some blood cells.
  • Signs of liver problems, such as yellowing of the skin and/or eyes (jaundice), associated or not with bleeding that appears under the skin as red spots and/or confusion (see section 2 "Take special care with Clopidogrel").
  • Swelling of the mouth or skin disorders such as rashes and itching, blisters on the skin.

These may be signs of an allergic reaction.

The most common side effect reported with Clopidogrel(affecting between 1 and 10 patients out of 100) is bleeding. Bleeding can occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, blood in urine. A reduced number of cases of bleeding in the blood vessels of the eyes, intracranial bleeding, pulmonary bleeding, or joint bleeding have also been reported.

If you experience prolonged bleeding while taking Clopidogrel Farmalid

If you cut or injure yourself, the bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medication, as it prevents the blood's ability to form clots. For minor cuts or injuries, such as cuts while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Take special care with Clopidogrel").

Other side effects reported with Clopidogrel are:

Common side effects (between 1 and 10 out of 100 people): Diarrhea, abdominal pain, indigestion, or heartburn.

Uncommon side effects (between 1 and 10 out of 1,000 people): Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, tingling sensation, and numbness.

Rare side effects (between 1 and 10 out of 10,000 people): Vertigo.

Very rare side effects (less than 1 in 10,000 people): Jaundice, severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions; swelling of the mouth; blisters on the skin, skin allergy; inflammation of the mouth mucosa (stomatitis); decreased blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste, eosinophilic pneumonia, acquired hemophilia A.

Side effects of unknown frequency: Hypersensitivity reactions.

In addition, your doctor may observe changes in the results of your blood or urine tests.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Clopidogrel Farmalid

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.

No special storage conditions are required.

Do not use this medication if you notice any visible signs of deterioration.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the SIGRE collection point at the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Package contents and additional information

Composition of Clopidogrel Farmalid

  • The active ingredient is clopidogrel. Each tablet contains 75 mg of clopidogrel (as besylate).
  • The other ingredients are: microcrystalline cellulose, spray-dried mannitol, hydroxypropylcellulose, crospovidone, citric acid, PEG 6,000, stearic acid, talc, hypromellose, lactose monohydrate, red iron oxide (E172), triacetin, and titanium dioxide (E171).

Appearance of the product and package contents

The Clopidogrel Farmalid tablets are round, biconvex, pink, and film-coated.

They are available in packages of 28 and 100 tablets in PVC/PE/PVDC-Aluminum or Aluminum-Aluminum blisters.

Only certain package sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Farmalider, S.A.

c/ Aragoneses 15

28108 Alcobendas - Madrid

Spain

Manufacturer

FARMALIDER, S.A.

c/ Aragoneses 15

28108 Alcobendas - Madrid

Spain

Or

PHARMATHEN S.A.

6, Dervenakion Str (Pallini Attikis)

  • GR-16351 - Greece

Date of the last revision of this package leaflet: October 2020

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS

Discuss questions about CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS?
CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS?
The active ingredient in CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS is clopidogrel. This information helps identify medicines with the same composition but different brand names.
Who manufactures CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS?
CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS is manufactured by Farmalider S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CLOPIDOGREL FARMALID 75 mg FILM-COATED TABLETS?
Other medicines with the same active substance (clopidogrel) include AGRELAN 75 mg FILM-COATED TABLETS, CLOPIDOGREL ALMUS 75 mg FILM-COATED TABLETS, CLOPIDOGREL ALTER 75 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media